Skip to main content
4th of July Sale — Get 40% off Vantage subscriptions
Published loading...Updated

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

Summary by Ground News
Pfizer/BioNtech's COVID-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant. With cases soaring, some countries have expanded vaccine booster programmes. Pfizer could be ready to file for approval for a redesigned vaccine, and mass produce it, as soon as March.
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Reuters broke the news in New York, United States on Sunday, January 23, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal